Another try: will spironolactone bring better outcomes in maintanance dialysis?
In ESRD is spironolactone an overACHIEVEr?
The ACHIEVE visual abstract
Does spironolactone decrease cardiovascular disease and heart failure hospitalizations in patients on dialysis?
Check out this crisp VA by Dr Akshaya Jayachandran.
NephJC Shorts: The end of the Fluid Wars?
NephJC Shorts: BedMed and Chronotherapy
Are E-Nudges Enough to Push Guideline-Based CKD Therapy?
Dialysis dreams and sleepless realities: the SLEEP-HD trial
Is Eculizumab a good Complement in STEC-HUS?
Optimizing “Sparse” Treatments for FSGS
Unlocking the door to living kidney donor paradise?
This week, nephrologists hope they found the key to no-dialysis-land, where kindness and detailed, multistep interventions make the path to kidney transplant much easier. This was foreseen in our Freely Filtered episode and disputed during #KidneyWK 2023 late-breaking clinical trials session. Still, when it comes to RCTs’ results, will it be Deja Vu or a happy ending?
